This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Kancera Ab, Pharmacia Ab. Active years: 2001-2016.
Company Filing History:
Years Active: 2001-2016
Title: Charles Hedgecock: Innovator in Pharmaceutical Compounds
Introduction
Charles Hedgecock is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues such as inflammation and cancer. With a total of 2 patents, Hedgecock's work exemplifies the intersection of innovation and healthcare.
Latest Patents
Hedgecock's latest patents include two important inventions. The first patent involves sulfonamide compounds, specifically a compound of formula (I), wherein A is S, O, or a double bond, and L is a substituted thiazolyl, phenyl, or pyridyl. This compound is particularly useful for the treatment of inflammation and cancer. The second patent focuses on 2-amino-5-pyrimidine acetic acid compounds, which relate to new benzimidazole compounds with a specific general structure (I).
Career Highlights
Throughout his career, Hedgecock has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Pharmacia AB and Kancera AB. His work in these organizations has allowed him to contribute to the advancement of medical science through innovative drug development.
Collaborations
Hedgecock has collaborated with several professionals in his field, including Eric Desarbre and Guido Kurz. These collaborations have likely enriched his research and contributed to the successful development of his patented compounds.
Conclusion
Charles Hedgecock's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patents reflect a commitment to addressing significant health challenges through scientific advancement.